Trials / Completed
CompletedNCT02483364
A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure)
A Phase II Clinical Trial to Assess the Effect of HC-SVT-1001 (Autologous Fat Stem Adult Mesenchymal Cells Expanded and Combined With a Tricalcium Phosphate Biomaterial) and HC-SVT-1002 (Allogeneic Fat Stem Adult Mesenchymal Cells Expanded and Combined With a Tricalcium Phosphate Biomaterial) in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Salvat · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose os this study is to evaluate the safety and effectiveness of HC-SVT-1001 and HC-SVT-1002 in the surgical treatment of atrophic nonunion in long bones.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment) | A single application in the context of a single surgical intervention. |
Timeline
- Start date
- 2015-11-10
- Primary completion
- 2020-05-18
- Completion
- 2020-10-20
- First posted
- 2015-06-26
- Last updated
- 2021-03-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02483364. Inclusion in this directory is not an endorsement.